Aug. 14, 2019
Posted by Lisa Sencen
We’re delighted to announce that Acting FDA Commissioner, Norman E. “Ned” Sharpless will deliver the keynote address at this year’s Rare Diseases & Orphan Products Breakthrough Summit. Sharpless, a physician and scientist, became Acting Commissioner of FDA earlier this year and previously served as the director of the National Cancer Institute.
In addition to the Acting Commissioner’s participation, we have an exciting two days in store for 800+ rare disease leaders. Join us this fall in Washington, DC for discussions on timely topics like gene therapy and advancing technology, insight from nearly 100 speakers, as well as valuable networking and much more.
Register today before pricing increases after Friday, August 23!